Clarity Medical Group Holding Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Clarity Medical Group Holding hat ein Gesamteigenkapital von HK$241.3M und eine Gesamtverschuldung von HK$0.0, was einen Verschuldungsgrad von 0% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen HK$296.9M bzw. HK$55.6M.

Wichtige Informationen

Verhältnis von Schulden zu Eigenkapital

HK$0

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	HK$147.13m
Eigenkapital	HK$189.52m
Gesamtverbindlichkeiten	HK$46.64m
Gesamtvermögen	HK$236.16m

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Investors Could Be Concerned With Clarity Medical Group Holding's (HKG:1406) Returns On Capital

Mar 21

Weak Statutory Earnings May Not Tell The Whole Story For Clarity Medical Group Holding (HKG:1406)

Dec 26

Clarity Medical Group Holding Limited's (HKG:1406) Shares Climb 28% But Its Business Is Yet to Catch Up

Aug 16

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: 1406Die kurzfristigen Aktiva des Unternehmens (HK$191.8M) übersteigen seine kurzfristigen Passiva (HK$37.9M).

Langfristige Verbindlichkeiten: 1406Die kurzfristigen Vermögenswerte des Unternehmens (HK$191.8M) übersteigen seine langfristigen Verbindlichkeiten (HK$17.8M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: 1406 ist schuldenfrei.

Schulden abbauen: 1406 hat keine Schulden im Vergleich zu vor 5 Jahren, als das Verhältnis von Schulden zu Eigenkapital 27.7% betrug.

Bilanz

Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: 1406 auf der Grundlage seines derzeitigen freier Cashflows über eine ausreichende Liquiditätsreserve für mehr als ein Jahr verfügt.

Vorhersage Cash Runway: 1406 über eine ausreichende Liquiditätsreserve für mehr als 3 Jahre verfügt, wenn der freie Cashflow weiterhin mit historischen Raten von 69.1% pro Jahr zurückgeht

Clarity Medical Group Holding Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

Full year 2024 earnings released: HK$0.14 loss per share (vs HK$0.006 loss in FY 2023)

Clarity Medical Group Holding Limited, Annual General Meeting, Aug 30, 2024

Clarity Medical Group Holding Limited Appoints Cheng Jessica as Independent Non-Executive Director and Audit Committee

Executive Director recently sold HK$5.6m worth of stock

Executive Director recently sold HK$157k worth of stock

Clarity Medical Group Holding Limited Announce Demise of Lau Wan Yee Joseph, Independent Non-Executive Director

Executive Director recently sold HK$482k worth of stock

Executive Director recently sold HK$2.0m worth of stock

Executive Director recently sold HK$2.0m worth of stock

First half 2024 earnings released: HK$0.038 loss per share (vs HK$0.015 profit in 1H 2023)

New major risk - Revenue size

New minor risk - Share price stability

Clarity Medical Group Holding Limited to Report First Half, 2024 Results on Nov 28, 2023

Clarity Medical Group Holding Limited Provides Earnings Guidance for the Six Months Ended 30 September 2023

Full year 2023 earnings released: HK$0.006 loss per share (vs HK$0.035 profit in FY 2022)

Clarity Medical Group Holding Limited, Annual General Meeting, Sep 20, 2023

Full year 2023 earnings released: HK$0.006 loss per share (vs HK$0.035 profit in FY 2022)

New minor risk - Financial data availability

Clarity Medical Group Holding Limited to Report Fiscal Year 2023 Results on Jun 27, 2023

Clarity Medical Group Holding Limited Provides Earnings Guidance for the Year Ended 31 March 2023

Executive Director recently bought HK$589k worth of stock

Investor sentiment improves as stock rises 16%

Investors Could Be Concerned With Clarity Medical Group Holding's (HKG:1406) Returns On Capital

Non-Executive Director exercised options to buy HK$4.5m worth of stock.

Weak Statutory Earnings May Not Tell The Whole Story For Clarity Medical Group Holding (HKG:1406)

Now 24% undervalued after recent price drop

Less than half of directors are independent

Clarity Medical Group Holding Limited to Report First Half, 2023 Results on Nov 28, 2022

Clarity Medical Group Holding Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 September 2022

Investor sentiment improved over the past week

Executive Director recently bought HK$110k worth of stock

Investor sentiment deteriorated over the past week

Executive Director recently bought HK$59k worth of stock

Executive Director recently bought HK$735k worth of stock

Clarity Medical Group Holding Limited's (HKG:1406) Shares Climb 28% But Its Business Is Yet to Catch Up

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: HK$0.035 (vs HK$0.095 in FY 2021)

Executive Director recently bought HK$166k worth of stock

Clarity Medical Group Holding Limited Announces Executive Changes

Full year 2022 earnings released: EPS: HK$0.035 (vs HK$0.095 in FY 2021)

Clarity Medical Group Holding Limited, Annual General Meeting, Aug 26, 2022

Clarity Medical Group Holding Limited to Report Fiscal Year 2022 Results on Jun 28, 2022

Clarity Medical Group Holding Limited Provides Consolidated Guidance for the Year Ended March 31, 2022

Executive Director recently sold HK$1.3m worth of stock

Less than half of directors are independent

Executive Director recently sold HK$378k worth of stock

Investor sentiment improved over the past week

Executive Director recently sold HK$58k worth of stock

Investor sentiment deteriorated over the past week

Insider recently bought HK$7.6m worth of stock

Clarity Medical Group Holding Limited has completed an IPO in the amount of HKD 217.6 million.

Less than half of directors are independent

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Liquiditätsreserve-Analyse

Entdecken Sie finanziell stabile Unternehmen